Subscribe to
our newsletters

Subscribe to our newsletters!

Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.

Search in Nordic Life Science Insight

-
October 10, 2019

Redoxis receives Horizon 2020 grant

Redoxis receives Horizon 2020 grant

-
-
October 10, 2019

The FET Open Horizon 2020 project under acronym NeutroCure, in which Redoxis is one of the partners, has been granted by the EU commission. The project is focused on development of smart amplifiers of reactive oxygen species to aberrant polymorphonuclear neutrophils for treatment of inflammatory and autoimmune diseases, cancer and myeloablation and is a collaboration with academic groups in Germany, United Kingdom, Ukraine, Spain and France. In the NeutroCure project we will be able to combine our knowledge and interest in redox regulation of the immune system with our preclinical in vivo model platform. Redoxis main role in the NeutroCure project will be preclinical efficacy and mode of action characterization. The project has a total budget of approximately 3 000 000 € over 5 years and Redoxis activities has been granted 400 000 €.

The post Redoxis receives Horizon 2020 grant appeared first on Redoxis.

Last updated:
October 10, 2019

Click here to read more about us!
Get in touch with us!
Visit us
Send us mail
Other articles published by
No items found.

The FET Open Horizon 2020 project under acronym NeutroCure, in which Redoxis is one of the partners, has been granted by the EU commission. The project is focused on development of smart amplifiers of reactive oxygen species to aberrant polymorphonuclear neutrophils for treatment of inflammatory and autoimmune diseases, cancer and myeloablation and is a collaboration with academic groups in Germany, United Kingdom, Ukraine, Spain and France. In the NeutroCure project we will be able to combine our knowledge and interest in redox regulation of the immune system with our preclinical in vivo model platform. Redoxis main role in the NeutroCure project will be preclinical efficacy and mode of action characterization. The project has a total budget of approximately 3 000 000 € over 5 years and Redoxis activities has been granted 400 000 €.

The post Redoxis receives Horizon 2020 grant appeared first on Redoxis.

Last updated:
October 10, 2019

Click here to read more about us!
Get in touch with us!
Visit us
Send us mail
Other articles published by
No items found.